Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

I. BACKGROUND

10 Plexxikon and Novartis filed a number of administrative motions to file under seal in connection 11 || with their summary judgment, Daubert, and in limine motions. See generally Sealing Order. On March 12 || 13, 2020, the Court issued a Sealing Order granting in part and denying in part the parties’ administrative 13 || motions to file under seal, and directing the parties “‘to file public versions of all documents for which the 14 || proposed sealing has been denied, as indicated in the chart above, within seven days from the date of this 15 || order.” Jd. at 39. 16 On March 20, 2020, counsel for Plexxikon twice attempted to file the Public Documents as 17 || attachments to a Notice of Compliance. Samuels Decl. 9 3-4. On both occasions, CM/ECF was unable 18 || to accept the filing, and instead indicated that “[a]n internal error has occurred” and that CM/ECF “could 19 || not open [the] context file.” Jd., Exs. A, B. 20 On March 23, 2020, counsel for Plexxikon contacted the California Northern District Court CM/ECF Help Desk at 866-638-7829. Id. 95. The Help Desk representative explained that the error 22 || may have been due…